I'm not sure about what Gillyad has coming; I'm sure whatever it is they will pay the piper at the gates of doom to get it rush-delivered to the winner's circle. FDA corruption sure makes it hard to be a smart investor in this sector. Very disheartening. Should we hope for a rush of approvals to hide their bias? Enough blowback might make that happen. If they'll bend over for the President and BP muscle, maybe public pressure can sway them too.